IBDEI2IK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42188,2)
 ;;=^5011598
 ;;^UTILITY(U,$J,358.3,42189,0)
 ;;=I82.401^^192^2136^10
 ;;^UTILITY(U,$J,358.3,42189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42189,1,3,0)
 ;;=3^Embolism/Thrombos Rt Lower Extrem Deep Veins,Acute
 ;;^UTILITY(U,$J,358.3,42189,1,4,0)
 ;;=4^I82.401
 ;;^UTILITY(U,$J,358.3,42189,2)
 ;;=^5007854
 ;;^UTILITY(U,$J,358.3,42190,0)
 ;;=I82.402^^192^2136^9
 ;;^UTILITY(U,$J,358.3,42190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42190,1,3,0)
 ;;=3^Embolism/Thrombos Lft Lower Extrem Deep Veins,Acute
 ;;^UTILITY(U,$J,358.3,42190,1,4,0)
 ;;=4^I82.402
 ;;^UTILITY(U,$J,358.3,42190,2)
 ;;=^5007855
 ;;^UTILITY(U,$J,358.3,42191,0)
 ;;=R60.9^^192^2136^4
 ;;^UTILITY(U,$J,358.3,42191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42191,1,3,0)
 ;;=3^Edema, unspec
 ;;^UTILITY(U,$J,358.3,42191,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,42191,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,42192,0)
 ;;=R60.1^^192^2136^2
 ;;^UTILITY(U,$J,358.3,42192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42192,1,3,0)
 ;;=3^Edema, generalized
 ;;^UTILITY(U,$J,358.3,42192,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,42192,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,42193,0)
 ;;=R60.0^^192^2136^3
 ;;^UTILITY(U,$J,358.3,42193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42193,1,3,0)
 ;;=3^Edema, localized
 ;;^UTILITY(U,$J,358.3,42193,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,42193,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,42194,0)
 ;;=M79.7^^192^2137^160
 ;;^UTILITY(U,$J,358.3,42194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42194,1,3,0)
 ;;=3^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,42194,1,4,0)
 ;;=4^M79.7
 ;;^UTILITY(U,$J,358.3,42194,2)
 ;;=^46261
 ;;^UTILITY(U,$J,358.3,42195,0)
 ;;=M80.061A^^192^2137^385
 ;;^UTILITY(U,$J,358.3,42195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42195,1,3,0)
 ;;=3^Path fx age-rel osteo, rt lwr leg, init
 ;;^UTILITY(U,$J,358.3,42195,1,4,0)
 ;;=4^M80.061A
 ;;^UTILITY(U,$J,358.3,42195,2)
 ;;=^5013459
 ;;^UTILITY(U,$J,358.3,42196,0)
 ;;=M80.062A^^192^2137^383
 ;;^UTILITY(U,$J,358.3,42196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42196,1,3,0)
 ;;=3^Path fx age-rel osteo, lft lwr leg, init
 ;;^UTILITY(U,$J,358.3,42196,1,4,0)
 ;;=4^M80.062A
 ;;^UTILITY(U,$J,358.3,42196,2)
 ;;=^5013465
 ;;^UTILITY(U,$J,358.3,42197,0)
 ;;=M80.071A^^192^2137^384
 ;;^UTILITY(U,$J,358.3,42197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42197,1,3,0)
 ;;=3^Path fx age-rel osteo, rt ank/ft, init
 ;;^UTILITY(U,$J,358.3,42197,1,4,0)
 ;;=4^M80.071A
 ;;^UTILITY(U,$J,358.3,42197,2)
 ;;=^5013477
 ;;^UTILITY(U,$J,358.3,42198,0)
 ;;=M80.072A^^192^2137^382
 ;;^UTILITY(U,$J,358.3,42198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42198,1,3,0)
 ;;=3^Path fx age-rel osteo, lft ank/ft init
 ;;^UTILITY(U,$J,358.3,42198,1,4,0)
 ;;=4^M80.072A
 ;;^UTILITY(U,$J,358.3,42198,2)
 ;;=^5013483
 ;;^UTILITY(U,$J,358.3,42199,0)
 ;;=M72.2^^192^2137^159
 ;;^UTILITY(U,$J,358.3,42199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42199,1,3,0)
 ;;=3^Fibromatosis, plantar fascial
 ;;^UTILITY(U,$J,358.3,42199,1,4,0)
 ;;=4^M72.2
 ;;^UTILITY(U,$J,358.3,42199,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,42200,0)
 ;;=M84.471A^^192^2137^410
 ;;^UTILITY(U,$J,358.3,42200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42200,1,3,0)
 ;;=3^Path fx rt ankl, init enc
 ;;^UTILITY(U,$J,358.3,42200,1,4,0)
 ;;=4^M84.471A
 ;;^UTILITY(U,$J,358.3,42200,2)
 ;;=^5013962
 ;;^UTILITY(U,$J,358.3,42201,0)
 ;;=M84.472A^^192^2137^396
 ;;^UTILITY(U,$J,358.3,42201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42201,1,3,0)
 ;;=3^Path fx lft ankl, init enc
 ;;^UTILITY(U,$J,358.3,42201,1,4,0)
 ;;=4^M84.472A
